Printer Friendly

Quest Diagnostics acquires laboratory services business from Boyce & Bynum Pathology Laboratories.

Global Banking News-February 12, 2019-Quest Diagnostics acquires laboratory services business from Boyce & Bynum Pathology Laboratories

(C)2019 ENPublishing -

Diagnostic information services company Quest Diagnostics (NYSE:DGX) revealed on Monday the completion of the acquisition of the clinical laboratory services business of Boyce & Bynum Pathology Laboratories (BBPL), a provider of diagnostic and clinical laboratory services in the Midwest, for an undisclosed amount.

Under the terms of a separate professional services agreement, Boyce and Bynum Pathology Professional Services Inc (BBPPS) is now the exclusive pathology provider for Quest Diagnostics clients in Missouri and a preferred pathology provider in the greater Midwestern region. Additional financial terms were not disclosed.

Through the acquisition, Quest brings a broader menu of innovative clinical laboratory and pathology services to patients and providers throughout the region.

The agreement will provide patients with access to an expanded network of service centres across the Midwest, for greater convenience.

((Distributed via M2 Communications -

COPYRIGHT 2019 Normans Media Ltd.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2019 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:Global Banking News (GBN)
Date:Feb 12, 2019
Previous Article:Agellan Commercial Real Estate Investment Trust declares final special distribution of additional units.
Next Article:Eniro reports on impairment of book values of goodwill in report for Q4 and full year 2018.

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters